Shandong Weigao Group (01066): November 2025 Monthly Return Highlights

Bulletin Express12-01

Shandong Weigao Group Medical Polymer Company Limited released its monthly return for November 2025, disclosing no adjustments to its total authorized share capital of RMB 457,063,232.4. The H shares authorized capital remained at 4,522,332,324 shares, par value RMB 0.1 each, while non-listed shares remained at 48,300,000, also par value RMB 0.1 each.

The total number of issued H shares (excluding treasury shares) decreased by 4,933,200 during the month, from 4,500,049,524 to 4,495,116,324. Correspondingly, treasury shares increased by 4,933,200, bringing the total to 27,216,000. All repurchases were recorded at prices ranging from HKD 5.2587 to HKD 5.6325. The total number of issued non-listed shares remained unchanged at 48,300,000.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment